Modeling Arrhythmias Using hPSC-Derived Cardiomyocytes and Tracking Their Excitability

Webinar: Modeling Arrhythmias Using hPSC-Derived Cardiomyocytes and Tracking Their Excitability

In this webinar, Drs. Vincenzo Macri and Stacie Chvatal discuss their current work on tools to generate human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and to measure these cells’ excitability. These tools enable modeling of arrhythmias using patient-derived and gene-edited hPSC lines associated with genetic mutations and drug-acquired arrhythmias.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.